MART-1(32-40)

MART-1(32-40) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells 1 (MART-1), specifically encompassing amino acids 32 to 40 of the protein sequence. As a well-characterized immunogenic epitope, this peptide plays a central role in studies of tumor immunology and T cell recognition, particularly in the context of melanoma research. Its precise sequence and defined immunological relevance make it a valuable reagent for investigations into antigen processing, presentation, and the mechanisms of immune surveillance against malignant cells. Researchers utilize this peptide to probe the specificity and activation of cytotoxic T lymphocytes (CTLs), facilitating advances in understanding tumor-associated antigens and their interaction with the adaptive immune system.

Antigen Presentation Studies: MART-1(32-40) is extensively employed to investigate the molecular dynamics of antigen processing and presentation by major histocompatibility complex (MHC) class I molecules. By serving as a model epitope, it enables researchers to analyze the efficiency and specificity with which antigen-presenting cells (APCs) display peptide fragments to CD8+ T cells. This approach is instrumental in dissecting the pathways of peptide loading, transport, and MHC stabilization, providing insight into the fundamental mechanisms that underlie cellular immune recognition in cancer and infectious disease models.

T Cell Activation and Functional Assays: The peptide is widely used in functional assays designed to assess CTL responses, including proliferation, cytokine secretion, and cytolytic activity. By pulsing APCs or target cells with MART-1(32-40), scientists can quantify antigen-specific T cell activation using readouts such as interferon-gamma release, cytotoxicity assays, and flow cytometric analysis of activation markers. These applications are critical for evaluating the potency and specificity of T cell responses in both basic research and translational immunology settings.

Epitope Mapping and Immunogenicity Profiling: Researchers utilize MART-1(32-40) in systematic epitope mapping to delineate the precise regions of the MART-1 protein that are recognized by T cell receptors (TCRs). Through comparative studies with peptide variants or truncated forms, the peptide helps define the minimal sequence required for effective immune recognition. This information is essential for understanding TCR-peptide-MHC interactions, guiding the design of peptide-based immunogens, and identifying candidate epitopes for immunotherapeutic development.

Quality Control in Peptide Synthesis and Immunoassays: As a well-established reference epitope, MART-1(32-40) serves as a positive control in peptide synthesis validation and immunoassay calibration. Laboratories frequently incorporate this peptide into quality control protocols for verifying the performance of peptide-MHC tetramers, ELISPOT assays, and flow cytometry reagents. Its consistent immunogenic properties allow for standardized assessment of assay sensitivity, specificity, and reproducibility across experimental platforms.

Adoptive Cell Transfer Research: In the context of adoptive T cell therapy studies, MART-1(32-40) is utilized to evaluate the specificity and functional competence of T cells engineered or expanded ex vivo for antigen recognition. By exposing candidate T cell populations to the peptide in vitro, researchers can monitor their ability to recognize and respond to tumor-associated antigens prior to in vivo application. These studies inform the optimization of cell selection, expansion protocols, and antigen-targeting strategies in preclinical models of immunotherapy.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Emu oil in combination with other active ingredients for treating skin imperfections